Skip to main content
SpringerLink
Log in

Pharmac, New Zealand's drug subsidy agency, has proposed changes to its cost-utility analysis methodology, particularly the discount rate and range of costs included,

  • News item
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Grocott R, Moodie P.PHARMAC seeks clinical feedback on its cost-utility analysis methodology. New Zealand Medical Journal 119: 97-107, No. 1239, 4 Aug 2006

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pharmac, New Zealand's drug subsidy agency, has proposed changes to its cost-utility analysis methodology, particularly the discount rate and range of costs included,. Pharmacoecon. Outcomes News 510, 3 (2006). https://doi.org/10.2165/00151234-200605100-00008

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200605100-00008

Keywords

Search

Navigation